Watts Gwilliam & Co., LLC Dexcom Inc Transaction History
Watts Gwilliam & Co., LLC
- $569 Million
- Q2 2025
A detailed history of Watts Gwilliam & Co., LLC transactions in Dexcom Inc stock. As of the latest transaction made, Watts Gwilliam & Co., LLC holds 36,546 shares of DXCM stock, worth $2.49 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
36,546
Previous 44,821
18.46%
Holding current value
$2.49 Million
Previous $3.06 Million
4.25%
% of portfolio
0.56%
Previous 0.61%
Shares
3 transactions
Others Institutions Holding DXCM
# of Institutions
1,109Shares Held
367MCall Options Held
5.36MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA48.3MShares$3.3 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.35 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$1.15 Billion0.06% of portfolio
-
Baillie Gifford & CO16.7MShares$1.14 Billion1.14% of portfolio
-
Geode Capital Management, LLC Boston, MA10.8MShares$734 Million0.07% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26.3B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...